Kratom Class Action Lawsuit Alleges Ingredients Are as Addictive as Opioids
Manufacturers should have known about and failed to disclose risks of painful kratom withdrawal symptoms.
October 22, 2024 By: Michael Adams
Manufacturers should have known about and failed to disclose risks of painful kratom withdrawal symptoms.
The FDA is requiring new label warnings for Ozempic, Wegovy, Mounjaro and all other GLP-1 drugs, indicating they may cause pulmonary aspiration during surgery.
To help the parties identify Suboxone lawsuits that can be used as representative samples in early bellwether trials, the federal judge presiding over the litigation has directed the parties to conduct a census of all tooth decay claims.
A California woman’s lawsuit alleges that Depo-Provera shots left her with life-long impairments, after she developed a meningioma that required brain tumor removal surgery.
"*" indicates required fields